BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Constantino Fernández Rivera, María Calvo Rodríguez, Andrés López Muñíz, Tamara Ferreiro Hermida, Rocío Seijo Bestilleiro, Concepción Andón Saavedra, Andrea Galego García, Angel Alonso Hernández. Trasplante renal de donante vivo ABO incompatible. Estudio de 48 pacientes tras desensibilizaciónNefrología 2019; 39(6): 612 doi: 10.1016/j.nefro.2019.02.010
2
Prashant Pandey, Divya Setya, Vijay Sinha, Anil Bhatt, Amit Devra, Abhideep Chaudhary, Shweta Ranjan, Roli Srivastava, Praveen Kumar, Mukesh Kumar Singh. Therapeutic apheresis in ABO ‐incompatible kidney and liver transplantation: A single‐center experience of 50 patients Therapeutic Apheresis and Dialysis 2021; 25(1): 103 doi: 10.1111/1744-9987.13495
3
Lionel Rostaing, Asma Allal, Arnaud del Bello, Federico Sallusto, Laure Esposito, Nicolas Doumerc, Bénédicte Debiol, Audrey Delas, Xavier Game, Nassim Kamar. Treatment of large plasma volumes using specific immunoadsorption to desensitize ABO-incompatible kidney-transplant candidatesJournal of Nephropathology 2016; 5(3): 90 doi: 10.15171/jnp.2016.17
4
F. Kleinclauss, A. Frontczak, N. Terrier, R. Thuret, M.-O. Timsit. Aspects immunologiques et immunosuppression en transplantation rénale, transplantations rénales ABO et HLA-incompatiblesProgrès en Urologie 2016; 26(15): 977 doi: 10.1016/j.purol.2016.08.015
5
Constantino Fernández Rivera, María Calvo Rodríguez, Andrés López Muñíz, Tamara Ferreiro Hermida, Rocío Seijo Bestilleiro, Concepción Andón Saavedra, Andrea Galego García, Angel Alonso Hernández. ABO incompatible live donor renal transplant. Study of 48 patients after desensitizationNefrología (English Edition) 2019; 39(6): 612 doi: 10.1016/j.nefroe.2019.12.006
6
Christos Iatrou, Vasileios Zavvos, Ploumis Passadakis, Smaragdi Marinaki, Andromachi Mitsioni, Ioannis Boletis. Nephrology Worldwide2021; : 543 doi: 10.1007/978-3-030-56890-0_40
7
S. Marinaki, C. Skalioti, J. Boletis. Glomerular Diseases and Renal Transplantation: Pathogenic Pathways and Evolution of Therapeutic InterventionsTransplantation Proceedings 2017; 49(2): 243 doi: 10.1016/j.transproceed.2016.11.035
8
Uri Galili. The Natural Anti-Gal Antibody As Foe Turned Friend In Medicine2018; : 73 doi: 10.1016/B978-0-12-813362-0.00005-1
9
Annelies E. de Weerd, Michiel G.H. Betjes. ABO-Incompatible Kidney Transplant OutcomesClinical Journal of the American Society of Nephrology 2018; 13(8): 1234 doi: 10.2215/CJN.00540118
10
Maurizio Salvadori, Aris Tsalouchos. Current protocols and outcomes of ABO-incompatible kidney transplantationWorld Journal of Transplantation 2020; 10(7): 191-205 doi: 10.5500/wjt.v10.i7.191
11
Kajal Chauhan, Anita A. Mehta. Rituximab in kidney disease and transplantAnimal Models and Experimental Medicine 2019;  doi: 10.1002/ame2.12064
12
Florian G Scurt, Lara Ewert, Peter R Mertens, Hermann Haller, Bernhard M W Schmidt, Christos Chatzikyrkou. Clinical outcomes after ABO-incompatible renal transplantation: a systematic review and meta-analysisThe Lancet 2019; 393(10185): 2059 doi: 10.1016/S0140-6736(18)32091-9